FDA Brief

Warning letters Drugs

FDA warning letter to

Alan Health Technologies Inc. dba Alan

LowIssued Feb 20Posted Mar 3Center for Drug Evaluation and Research (CDER)

FDA warns Alan Health Technologies over website falsely labeling compounded semaglutide and tirzepatide as Alan-made.

What happened

FDA reviewed https://www.alanmeds.com in December 2025 and saw that it offers compounded semaglutide and tirzepatide drug products. FDA says pictured labels identify “Alan” in a way that suggests Alan is the compounder, when FDA says it is not. FDA calls the labeling and advertising false or misleading, so the drugs are misbranded (falsely labeled or advertised) and were introduced into interstate commerce.

What FDA found

  1. Website labels for compounded semaglutide and tirzepatide name “Alan,” suggesting Alan is the compounder even though FDA says it is not.

    FDCA § 502(a) [21 U.S.C. § 352(a)]; 21 CFR § 201.1(h)(2)
  2. The website’s advertising and promotion of these compounded drugs are false or misleading for the same reason.

    FDCA § 502(bb) [21 U.S.C. § 352(bb)]
  3. The misbranded compounded drugs were introduced or delivered for introduction into interstate commerce.

    FDCA § 301(a) [21 U.S.C. § 331(a)]
  4. Receiving misbranded drugs in interstate commerce, or delivering or offering to deliver them, is also prohibited.

    FDCA § 301(c) [21 U.S.C. § 331(c)]

What FDA wants

Within 15 working days of receipt, send OCQC in CDER’s Office of Compliance a written response describing steps taken, including identifying the entities that produce the compounded products, providing sample labeling, and addressing or correcting other website claims.

Who should pay attention

  • telehealth companies selling compounded semaglutide or tirzepatide
  • compounders whose drugs are sold under another company’s brand
  • online marketers and pharmacies using white-label drug labels

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Bella’s Nutri Shop Inc.

    Bella’s Nutri Shop sells “Tawon Liar” as an unapproved drug with hidden dexamethasone, tapentadol, and meloxicam.

    High risk
  4. RonanRx, Inc. dba RonanRx

    FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.

    Low